A0A4Y5UGE4 (A0A4Y5UGE4_HUMAN) Homo sapiens (Human)
T-cell surface glycoprotein CD4 UniProtKBInterProInteractive Modelling
458 aa; Sequence (Fasta) ;
1 identical sequence: Homo sapiens: P01730
It is possible new templates exist for this target since these models were created.
Available Structures
79 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of a complete ternary complex of T cell receptor, peptide-MHC and CD4 |
Heteromer A0A5B9; P01730; P01848; P01903; P01911; | 99.45 | ||||
| Structural basis of coreceptor recognition by HIV-1 envelope spike |
Heteromer P01730; P51681; Q70145; | 100 | 6×NAG; 2×NAG; 1×NAG; 7×NAG; 1×A2G; | |||
| cryoEM reconstruction of the HIV gp140 in complex with the extracellular domains of CD4 and the adn… |
Heteromer P01730; Q2N0S6; | 100.0 | ||||
| Initial contact of HIV-1 Env with CD4: Cryo-EM structure of BG505 DS-SOSIP trimer in complex with C… |
Heteromer P01730; Q2N0S6; | 100 | ||||
| Crystal structure of the anti-CD4 adnectin 6940_B01 as a complex with the extracellular domains of … |
Heteromer P01730; | 100.0 | 1×NAG; 1×SO4; | |||
| Structure of HIV-1 gp120 with gp41-Interactive Region: Layered Architecture and Basis of Conformati… |
Heteromer P01730; | 100 | 10×NAG; | |||
| Structure of HIV-1 gp120 with gp41-Interactive Region: Layered Architecture and Basis of Conformati… |
Heteromer P01730; | 100 | 1×NAG; 10×NAG; | |||
| Crystal structure of murine 2D5 Fab, a potent anti-CD4 HIV-1-neutralizing antibody in complex with … |
Heteromer P01730; | 100 | ||||
| HIV-1 gp120 Envelope Glycoprotein (I109C, T257S, S334A, S375W, Q428C) Complexed with CD4 and Antibo… |
Heteromer P01730; Q6N030; Q6P5S8; Q993A8; | 100 | 1×GLC; 14×NAG; | |||
| HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E267C, S334A, S375W) Complexed with CD4 and Antibo… |
Heteromer P01730; Q6N030; Q6P5S8; Q993A8; | 100 | 1×GLC; 13×NAG; | |||
| HIV-1 gp120 Envelope Glycoprotein(S334A) Complexed with CD4 and Antibody 17b |
Heteromer P01730; Q49DS8; Q6N095; Q6P5S8; | 100 | 13×NAG; 3×HEZ; 1×TRS; | |||
| HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E268C, S334A, S375W) Complexed with CD4 and Antibo… |
Heteromer P01730; P19551; Q6P5S8; | 100 | 1×GLC; 13×NAG; 1×HEZ; | |||
| HIV-1 gp120 Envelope Glycoprotein (T123C, T257S, S334A, S375W, G431C) Complexed with CD4 and Antibo… |
Heteromer P01730; P19551; Q6P5S8; | 100 | 1×GLC; 11×NAG; 2×EDO; 1×HEZ; | |||
| HIV-1 gp120 Envelope Glycoprotein (T257S, S334A, S375W) Complexed with CD4 and Antibody 17b |
Heteromer P01730; P19551; Q6P5S8; | 100 | 1×GLC; 13×NAG; 3×EDO; 1×HEZ; 1×IPA; | |||
| HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B |
Heteromer P01730; P04578; | 100 | 2×NAG; 12×NAG; 1×IPA; | |||
| HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B |
Heteromer P01730; P04578; | 100 | 2×NAG; 12×NAG; 1×IPA; | |||
| HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, T257S, V275C, S334A, S375W, A433M) Complexed with CD… |
Heteromer P01730; P19551; Q6P5S8; | 100 | 12×NAG; 1×HEZ; | |||
| HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY |
Heteromer P01730; P04578; | 100 | 4×NAG; 7×NAG; | |||
| HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M) Com… |
Heteromer P01730; P19551; Q6P5S8; | 100 | 1×GLC; 9×NAG; | |||
| HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T123C, T257S, V275C,S334A, S375W, Q428C, G431… |
Heteromer P01730; Q6N030; Q6P5S8; Q8Q7Z9; | 100 | 1×GLC; 8×NAG; | |||
| HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B |
Heteromer P01730; P35961; | 100 | 14×NAG; | |||
| HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B |
Heteromer P01730; P35961; | 100 | 14×NAG; | |||
| Crystal structure of fully glycosylated HIV-1 gp120 core bound to CD4 and 17b Fab |
Heteromer P01730; P35961; | 100 | 1×NAG; 4×NAG; 3×NAG; 1×NAG; | |||
| Model of gp120, including variable regions, in complex with CD4 and 17b |
Heteromer P01730; P04578; | 100 | ||||
| negative stain EM of BG505 SOSIP.664 in complex with sCD4, 17b, and 8ANC195 |
Heteromer P01730; P35961; | 100 | 45×NAG; | |||
| cryo-ET subtomogram averaging of BG505 SOSIP.664 in complex with sCD4, 17b, and 8ANC195 |
Heteromer P01730; P35961; | 100 | 45×NAG; | |||
| crystal structure of CD4-D1D2 with Nb457 |
Heteromer P01730; | 100 | ||||
| Crystal structure of HIV-1 primary receptor CD4 in complex with a potent antiviral antibody |
Heteromer P01730; | 100 | ||||
| Crystal structure of CD4 mutant bound to HLA-DR1 |
Heteromer P01730; P01903; P01911; P03437; | 98.86 | 1×GOL; | |||
| Structure of tyrosine-sulfated 412d antibody complexed with HIV-1 YU2 gp120 and CD4 |
Heteromer A4F255; P01730; P35961; | 100 | 16×NAG; 2×MLA; 4×EDO; | |||
| Crystal structure of non-neutralizing, A32-like antibody 2.2c in complex with HIV-1 Env gp120 |
Heteromer P01730; Q73372; | 100 | 8×NAG; | |||
| CRYSTAL STRUCTURE OF THE HUMAN CD4 N-TERMINAL TWO DOMAIN FRAGMENT COMPLEXED TO A CLASS II MHC MOLEC… |
Heteromer P01730; P01910; P02789; P06343; | 100 | ||||
| Crystal structure of CD4 mutant bound to HLA-DR1 |
Heteromer P01730; P01903; P01911; P03437; | 97.71 | 5×GOL; | |||
| structure of gp120/CD4 with a non-canonical surface |
Heteromer G4XFJ5; P01730; | 100 | 8×NAG; 1×EPE; | |||
| Structure of HIV-1 CH119 SOSIP.664 trimer in complex with CD4 molecules |
Heteromer A1EAH4; P01730; | 100 | 18×NAG; | |||
| Crystal structure of non-neutralizing and ADCC-potent antibody N5-i5 in complex with HIV-1 clade A/… |
Heteromer P01730; Q0ED31; | 100 | 10×NAG; 3×MRD; 1×GOL; | |||
| Crystal structure of 8ANC195 Fab in complex with gp120 of 93TH057 HIV-1 and soluble CD4 D1D2 |
Heteromer P01730; Q0ED31; | 99.4 | 2×NAG; 1×NAG; 2×NAG; 1×NAG; 1×EPE; 2×BEN; 3×NAG; | |||
| Structure of HIV-1 BG505 SOSIP-HT2 in complex with two CD4 molecules (class I) |
Heteromer P01730; Q2N0S5; Q2N0S6; | 100 | 4×NAG; 4×NAG; 1×NAG; 7×NAG; | |||
| Cryo-EM model of B41 SOSIP.664 in complex with soluble CD4 (D1-D2) and fragment antigen binding var… |
Heteromer B3UES2; B3UEZ6; P01730; | 100 | 12×NAG; 12×NAG; 3×NAG; 6×NAG; 24×NAG; | |||
| anti-HIV-1 gp120-sCD4 complex antibody CG10 Fab in complex with B41-sCD4 |
Heteromer B3UES2; P01730; | 100 | ||||
| Structure of HIV-1 BG505 SOSIP-HT1 in complex with one CD4 molecule |
Heteromer P01730; Q2N0S5; | 100 | 5×NAG; 2×NAG; 1×NAG; 1×NAG; 35×NAG; | |||
| Cryo-EM structure of BG505 SOSIP HIV-1 Env trimer in complex with CD4 receptor (D1D2) and broadly n… |
Heteromer P01730; Q2N0S6; | 100 | 2×NAG; 8×NAG; 11×NAG; 1×NAG; 30×NAG; | |||
| Structural basis of coreceptor recognition by HIV-1 envelope spike |
Heteromer P01730; P51681; Q70145; | 100 | 6×NAG; 2×NAG; 1×NAG; 7×NAG; 1×BMA; 1×A2G; | |||
| Crystal Structure of PGT 135 Fab in Complex with gp120 Core Protein from HIV-1 Strain JR-FL Bound t… |
Heteromer P01730; Q75760; | 100 | 1×NAG; 1×NAG; 1×NAG; 1×PG4; 6×NAG; | |||
| Crystal Structure of PGT124 Fab bound to HIV-1 JRCSF gp120 core and to CD4 |
Heteromer P01730; P0DOX5; P0DOY3; P20871; | 100 | 1×NAG; 8×NAG; 1×CL; 1×GOL; | |||
| Crystal structure of HIV-1 JR-FL gp120 core protein containing the third variable region (V3) compl… |
Heteromer P01730; Q75760; | 100 | 1×NAG; 3×NAG; 5×SO4; 3×XYL; | |||
| Crystal structure of clade C gp120 in complex with sCD4 and 21c Fab |
Heteromer P01730; Q1PHM6; | 100 | 4×NAG; | |||
| Structure of Simian Immunodeficiency Virus Envelope Spikes bound with CD4 and Monoclonal Antibody 3… |
Heteromer A0A3B6UDT5; P01730; | 100 | ||||
| Structure of Simian Immunodeficiency Virus Envelope Spikes bound with CD4 and Monoclonal Antibody 3… |
Heteromer A0A3B6UDT5; P01730; | 100 | ||||
| Envelope glycoprotein gp120 core from HIV type 2 bound to the first two domains of human soluble CD… |
Heteromer P01730; P20872; | 100.0 | 1×NAG; 1×NAG; 6×NAG; | |||
| Cryo-EM structure of a BG505 Env-sCD4-17b-8ANC195 complex |
Heteromer P01730; Q2N0S6; | 100 | 3×NAG; 6×NAG; | |||
| BG505 SOSIP in complex with sCD4, 17b, 8ANC195 |
Heteromer P01730; Q2N0S5; Q2N0S7; | 100 | 6×NAG; 3×NAG; 6×NAG; 18×NAG; | |||
| Asymmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with DDM |
Heteromer B3UES2; B3UEZ6; P01730; | 100 | 16×NAG; 10×NAG; 2×NAG; 4×NAG; 1×NAG; 3×LMT; 24×NAG; | |||
| CD4- and 17-bound HIV-1 Env B41 SOSIP frozen with LMNG |
Heteromer B3UES2; B3UEZ6; P01730; | 100 | 24×NAG; 3×NAG; 9×NAG; | |||
| Symmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with DDM |
Heteromer B3UES2; B3UEZ6; P01730; | 100 | 24×NAG; 3×NAG; 3×NAG; 18×NAG; 3×LMT; | |||
| Asymmetrically open conformational state (Class I) of HIV-1 Env trimer BG505 SOSIP.664 in complex w… |
Heteromer P01730; Q2N0S6; | 100 | 4×NAG; 2×NAG; 1×NAG; 21×NAG; | |||
| Asymmetrically open conformational state (Class II) of HIV-1 Env trimer BG505 SOSIP.664 in complex … |
Heteromer P01730; Q2N0S6; | 100 | 2×NAG; 3×NAG; 24×NAG; | |||
| B41 SOSIP.664 in complex with soluble CD4 (D1-D2), the co-receptor mimicking antibody 21c and the b… |
Heteromer B3UES2; B3UEZ6; P01730; | 100 | 15×NAG; 6×NAG; 3×NAG; 3×NAG; 27×NAG; | |||
| Asymmetric model of CD4-bound B41 HIV-1 Env SOSIP in complex with small molecule GO52 |
Heteromer B3UES2; B3UEZ6; P01730; | 100 | 3×NAG; 1×NAG; 23×NAG; 3×UOV; | |||
| Symmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with small molecule GO52 |
Heteromer B3UES2; B3UEZ6; P01730; | 100 | 3×NAG; 3×NAG; 27×NAG; 3×UOV; | |||
| CD4- and 17-bound HIV-1 Env B41 SOSIP in complex with small molecule GO35 |
Heteromer B3UES2; B3UEZ6; P01730; | 100 | 3×NAG; 3×NAG; 27×NAG; 3×N07; | |||
| Solution structure of T-cell surface glycoprotein CD4 and Proto-oncogene tyrosine-protein kinase LC… |
Heteromer P01730; P06239; | 97.37 | 1×ZN; | |||
| HIV-1 Nef in complex with the CD4 cytoplasmic domain and the AP2 clathrin adaptor complex |
Heteromer P01730; P03406; P18484; P53680; P63010; Q96CW1; | 100 | ||||
| CD4 endocytosis motif bound to the Focal Adhesion Targeting (FAT) domain of the Focal Adhesion Kina… |
Heteromer P01730; Q05397; | 100 | ||||
| AP2 CLATHRIN ADAPTOR CORE with Dileucine peptide RM(phosphoS)QIKRLLSE |
Heteromer P01730; P17427; P62743; P63010; P84092; | 100 | 14×SO4; | |||
| AP2 CLATHRIN ADAPTOR CORE with CD4 Dileucine peptide RM(phosphoS) EIKRLLSE Q to E mutant |
Heteromer P01730; P17427; P62743; P63010; P84092; | 88.89 | 15×SO4; | |||
| AP2 clathrin adaptor mu2T156-phosphorylated core with two cargo peptides in open+ conformation |
Heteromer P01730; P18484; P62744; P63010; P84092; | 100 | ||||
| AP2 clathrin adaptor core with two cargo peptides in open+ conformation |
Heteromer P01730; P18484; P62743; P63010; P84092; Q3ZC13; | 100 | ||||
| STRUCTURES OF AN HIV AND MHC BINDING FRAGMENT FROM HUMAN CD4 AS REFINED IN TWO CRYSTAL LATTICES | homo-2-mer | 99.44 | ||||
| REFINEMENT AND ANALYSIS OF THE FIRST TWO DOMAINS OF HUMAN CD4 | homo-2-mer | 100 | ||||
| STRUCTURES OF AN HIV AND MHC BINDING FRAGMENT FROM HUMAN CD4 AS REFINED IN TWO CRYSTAL LATTICES | homo-2-mer | 100 | ||||
| STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD4, TETRAGONAL CRYSTAL FORM | monomer | 100 | ||||
| STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD4, MONOCLINIC CRYSTAL FORM | monomer | 100 | ||||
| STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD4, TRIGONAL CRYSTAL FORM | monomer | 100 | ||||
| STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD4 MUTANT WITH GLY 47 REPLACED BY SER | monomer | 99.44 | ||||
| STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD4 | monomer | 100 | ||||
| STRUCTURE OF T-CELL SURFACE GLYCOPROTEIN CD4 MUTANT WITH PHE 43 REPLACED BY VAL | monomer | 99.44 | ||||
| NMR structure of the transmembrane and cytoplasmic domains of human CD4 | monomer | 91.94 | ||||
| SOLUTION STRUCTURE OF THE HUMAN CD4 (403-419) RECEPTOR PEPTIDE, NMR, 32 STRUCTURES | monomer | 100 | ||||
4 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8fyi.1.G | monomer | 0.76 | 100.00 | |||
| 2klu.1.A | monomer | 0.69 | 91.80 | |||
| 7db6.1.D | monomer | 0.55 | 20.22 | |||
| 6oel.1.E | monomer | 0.53 | 17.34 | |||